Plasma-derived therapy: Can the survivors of COVID-19 help the defenseless?

Nour Majbour; Omar El-Agnaf

doi:10.1515/dx-2020-0053

Plasma-derived therapy: Can the survivors of COVID-19 help the defenseless?

Nour Majbour, Omar El-Agnaf^*

^*Corresponding author for this work

QBRI - Neurological Disorders Research Center

Hamad bin Khalifa University

Research output: Contribution to journal › Review article › peer-review

2 Citations (Scopus)

Abstract

Following the unprecedented global Coronavirus Disease 2019 (COVID-19) outbreak, multiple medical countermeasures ramped up to combat the virus and contain the spread of the pandemic. Despite continued uncertainty and a lack of clarity about the COVID-19, researchers have made tremendous strides in the development of prevention and treatment strategies. In this article, we focus on the use of convalescent plasma as therapeutic approach against COVID-19 infection.

Original language	English
Pages (from-to)	373-376
Number of pages	4
Journal	Diagnosis
Volume	7
Issue number	4
DOIs	https://doi.org/10.1515/dx-2020-0053
Publication status	Published - 1 Dec 2020

Keywords

COVID-19
convalescent plasma
pandemic
plasma-derived therapy
treatment

Access to Document

10.1515/dx-2020-0053

Cite this

@article{e8184f80e9e948418111d048be3eb5ed,

title = "Plasma-derived therapy: Can the survivors of COVID-19 help the defenseless?",

abstract = "Following the unprecedented global Coronavirus Disease 2019 (COVID-19) outbreak, multiple medical countermeasures ramped up to combat the virus and contain the spread of the pandemic. Despite continued uncertainty and a lack of clarity about the COVID-19, researchers have made tremendous strides in the development of prevention and treatment strategies. In this article, we focus on the use of convalescent plasma as therapeutic approach against COVID-19 infection.",

keywords = "COVID-19, convalescent plasma, pandemic, plasma-derived therapy, treatment",

author = "Nour Majbour and Omar El-Agnaf",

note = "Publisher Copyright: {\textcopyright} 2020 Nour Majbour and Omar El-Agnaf, published by De Gruyter, Berlin/Boston 2020.",

year = "2020",

month = dec,

day = "1",

doi = "10.1515/dx-2020-0053",

language = "English",

volume = "7",

pages = "373--376",

journal = "Diagnosis",

issn = "2194-8011",

publisher = "Walter de Gruyter GmbH",

number = "4",

}

TY - JOUR

T1 - Plasma-derived therapy

T2 - Can the survivors of COVID-19 help the defenseless?

AU - Majbour, Nour

AU - El-Agnaf, Omar

PY - 2020/12/1

Y1 - 2020/12/1

N2 - Following the unprecedented global Coronavirus Disease 2019 (COVID-19) outbreak, multiple medical countermeasures ramped up to combat the virus and contain the spread of the pandemic. Despite continued uncertainty and a lack of clarity about the COVID-19, researchers have made tremendous strides in the development of prevention and treatment strategies. In this article, we focus on the use of convalescent plasma as therapeutic approach against COVID-19 infection.

AB - Following the unprecedented global Coronavirus Disease 2019 (COVID-19) outbreak, multiple medical countermeasures ramped up to combat the virus and contain the spread of the pandemic. Despite continued uncertainty and a lack of clarity about the COVID-19, researchers have made tremendous strides in the development of prevention and treatment strategies. In this article, we focus on the use of convalescent plasma as therapeutic approach against COVID-19 infection.

KW - COVID-19

KW - convalescent plasma

KW - pandemic

KW - plasma-derived therapy

KW - treatment

UR - https://www.scopus.com/pages/publications/85104102703

U2 - 10.1515/dx-2020-0053

DO - 10.1515/dx-2020-0053

M3 - Review article

C2 - 32692700

AN - SCOPUS:85104102703

SN - 2194-8011

VL - 7

SP - 373

EP - 376

JO - Diagnosis

JF - Diagnosis

IS - 4

ER -

Plasma-derived therapy: Can the survivors of COVID-19 help the defenseless?

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this